Bubiński R
Kardiol Pol. 1989;32(6):334-41.
Effect of dipyridamole on sinoatrial node function was evaluated in 24 patients during invasive cardiac electrophysiological examination. 3 multipolar USCI electrodes were inserted into the heart through femoral veins using Seldinger's method. Intracardiac potentials (A, H, V) and ecg tracings (I, II, III, aVR leads) were recorded during sinus rhythm and right atrial stimulation - continous, with gradually increasing pacing frequency and during extrastimulation, with gradually shortening of coupling interval. 0.5 mg/kg b.w. of dipyridamole (Curantyl, Germed, GDR) was intravenously administrated. During the initial examination and 5 minutes after the end of a drug injection following parameters were estimated: sinus cycle length (SCL), sinoatrial conduction time using Narula's and Strauss's methods (respectively SACTN, SACTS), maximal, corrected and standardized sinus node recovery time (respectively SNRTmax, SNRTcor, SNRTnorm) and maximal second postimulation pause (II pause max). Statistically significant (p less than 0.01) shortening of SCL by 26%, SACTN by 17%, SACTS by 13% SNRT max by 21%, II pause max by 26% was observed after dipyridamole administration. Only in the patient with sinoatrial node dysfunction dangerous bradycardia occurred.
在24例患者进行有创心脏电生理检查期间,评估了双嘧达莫对窦房结功能的影响。采用Seldinger法通过股静脉将3根多极USCI电极插入心脏。在窦性心律和右心房刺激期间记录心内电位(A、H、V)和心电图描记(I、II、III、aVR导联),刺激方式为连续刺激,起搏频率逐渐增加,以及额外刺激,耦合间期逐渐缩短。静脉注射0.5mg/kg体重的双嘧达莫(潘生丁,德国默克公司,德意志民主共和国)。在初始检查期间以及药物注射结束后5分钟,评估以下参数:窦性周期长度(SCL)、使用Narula法和Strauss法的窦房传导时间(分别为SACTN、SACTS)、最大、校正和标准化窦房结恢复时间(分别为SNRTmax、SNRTcor、SNRTnorm)以及最大二次刺激后间歇(II间歇max)。双嘧达莫给药后,观察到SCL显著缩短(p小于0.01)26%,SACTN缩短17%,SACTS缩短13%,SNRT max缩短21%,II间歇max缩短26%。仅在1例窦房结功能障碍患者中出现了危险的心动过缓。